Inhibition of fatty-acid amide hydrolase and CB1 receptor antagonism differentially affect behavioural responses in normal and PCP-treated rats. [electronic resource]
- The international journal of neuropsychopharmacology 04 2010
- 373-86 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1469-5111
10.1017/S146114570999023X doi
Amidohydrolases--metabolism Amphetamine--pharmacology Animals Autoradiography--methods Behavior, Animal--drug effects Benzamides--pharmacology Cannabinoid Receptor Modulators--metabolism Carbamates--pharmacology Central Nervous System Stimulants--pharmacology Cyclohexanols--pharmacology Drug Administration Schedule Drug Interactions Enzyme Inhibitors--pharmacology Guanosine 5'-O-(3-Thiotriphosphate)--metabolism Hallucinogens--pharmacology Interpersonal Relations Male Memory, Short-Term--drug effects Motor Activity--drug effects Neuropsychological Tests Phencyclidine--pharmacology Piperidines--pharmacology Protein Binding--drug effects Pyrazoles--pharmacology Rats Rats, Wistar Receptor, Cannabinoid, CB1--agonists Statistics, Nonparametric Sulfur Isotopes--metabolism Time Factors